July 90,733,888 1,027,886 10,367,437 92,784
UPDATED WEEKLY - Last updated on 26 July 2022, 7:00 pm PST, John Hopkins Corona Virus Dashboard and Worldometer
John Hopkins Worldometer
Recovered - Recovered - 546,865,657
POPULATION - is 334,876,997* as of 26 July 2022, 7:00 pm PST, based on Census U.S. and World Population Clock.
* no updated information at this reporting
Cases in the U.S.
Recovered - Recovered - 87,648,838
Cases in California
Recovered - Recovered - 9,726,208
07/26/2022 Cases (WHO) Deaths (WHO) Recovered (WHO)
** no change
*** no updated information at this reporting
United States progress Updated 26 July 2022, 7:00 pm PST,
** no updated information at this reporting
Okay, Okay…..What the………
Monkeypox: What we know about the virus as the WHO considers if the outbreak is an 'emergency'. The World Health Organization, WHO, described the outbreak as “unusual” and the continuing spread was worrying enough to convene its expert committee to decide whether the disease should be declared a ‘public health emergency’ of international concern. That label would give this tropical disease the same designation and attention as: Zika, Ebola or more recently COVID-19.
The current outbreak is unusual because the virus is spreading outside West and Central Africa, where it has been prevalent for decades. More than 1,300 cases have been reported globally across 31 countries, according to the CDC.
Monkeypox has historically been a disease limited to Africa and neglected by the rest of the world. \
Monkeypox is a relative of smallpox, a disease eradicated in 1980, is less transmissible, causes milder symptoms and is less deadly. Today, scientists are puzzled how it managed to cause a sizeable sudden global outbreak and why the overwhelming majority of patients infected are men who have sex with men.
NEXT PANDEMIC THREAT CAN COME FROM EVERYWHERE, PUBLIC HEALTH EXPERT SAYS. The U.S. has confirmed 45 monkeypox cases across 15 states and Washington D.C. No deaths have been reported.
Monkeypox normally begins with symptoms similar to the:
The disease progresses to a painful rash that can spread all over the body. Most patients recover in 2 - 4 weeks without specific medical treatment. Some patients only develop a rash on the genitals or anus before experiencing flulike symptoms. It’s unclear if the virus can spread through semen or vaginal fluid like sexually transmitted diseases. The virus can spread through direct contact with sores, bodily fluids or materials such as clothes or bedsheets. In other cases, patients developed a rash without any flu like symptoms.
Monkeypox can also spread through respiratory droplets when in close, sustained face-to-face contact. The virus doesn’t appear to linger in the air or transmit through short periods of shared airspace such as casual conversations.
The CDC does not know if the virus can spread from infected people with mild or no symptoms. 75% of monkeypox patients in the U.S. reported exposure during international travel. A few patients are unsure how they caught monkeypox, which suggests the virus maybe spreading within the U.S. at a low level. Those diagnosed with monkeypox during the current outbreak, have reported close physical contact with people infected with the virus.
The U.S. performed 300 tests for orthopox, the family of viruses that includes monkeypox, smallpox, horsepox, cowpox, camelpox and many other -pox viruses of animals,” indicated Amesh A. Adalja, M.D., a senior scholar at the Johns Hopkins Center for Health Security. Each orthopox virus has its own personality. Those testing positive for orthopox are presumed to have monkeypox until the Atlanta CDC confirms the diagnosis.
Jynneos, a small pox vaccine approved to fight monkeypox, is a two-dose vaccine, approved by the Food and Drug Administration for people 18 and older. The U.S. also has an older generation smallpox vaccine, ACAM2000, which also prevents the monkeypox infection. The CDC generally recommends Jynneos because ACAM2000 can have severe side effects.
Some monkeypox patients also have sexually transmitted diseases, CDC says. PUBLISHED FRI, JUN 10 20221:35 PM EDTUPDATED FRI, JUN 10 2022, 6:15 PM EDT.
“It’s important to be aware that monkeypox cases may present similar to some sexually transmitted infections and mistaken for other diagnoses,” Walensky said.
The Omicron subvariants BA.4 and BA.5 have together become dominant in the U.S., the C.D.C. estimates. This milestone comes less than six months after first being detected in South Africa and as the federal government considers an Omicron-specific booster dose for adults in the fall. Of new cases in the United States, BA.4 made up 15.7 % and BA.5 made up 36.6 %, together averaging 52 %, numbers that should rise in the weeks to come.
An expert committee recommended the Food and Drug Administration plan for an updated booster shot of the coronavirus vaccines that targets some form of the Omicron variant, even though the virus might evolve again by the fall.
BA.4 and BA.5 exhibit qualities of escape artists, able to elude antibodies produced after coronavirus vaccinations and infections, including infections caused by earlier versions of Omicron. This may explain why these sub-variants have spread even faster.
Hospitalizations nationwide were up 6 % in the last two weeks, an average of 31,000 a day, according to federal data. New deaths have stayed below 400 per day. The spread of the virus is a regional affair. In the Northeast and Midwest, cases have been declining while in the South and West, cases are increasing.
Across the nation, public health rules continue to be lifted, including ending an indoor mask mandate for Alameda County, the San Francisco Bay Area’s second-most populous county. In New York City, are retiring mask requirements. Even the longstanding requirement to test for the coronavirus before flying to the U.S. from abroad .
Why boosted Americans seem to be getting more COVID-19 infections. JUNE 2, 2022 / 2:40 PM . COVID-19 cases began to accelerate in the spring, federal data suggests the rate of breakthrough COVID infections was worse in April in those boosted compared to those un-boosted. Rates of deaths and hospitalizations remained the lowest among the boosted.
The shift underscores the growing complexity of measuring vaccine effectiveness at this stage of the pandemic. More boosted Americans have abandoned "prevention behaviors" like wearing masks and are vulnerable to catching and spreading the virus, at a time when officials are contemplating re-imposing pandemic measures.
"Home testing has become, the single biggest concern in developed countries that can interfere with our measurements," stated CDC's Ruth Link-Gelles at the National Foundation for Infectious Diseases conference.
CDC Director Dr. Walensky indicated her agency was in talks with the Food and Drug Administration regarding extending the second boosters option to more adults where only adults 50 and over and some immunocompromised are eligible to receive a fourth dose.
CDC Recommends COVID-19 Vaccinations for Young Kids. Immediate Release: Saturday, June 18, 2022. CDC Director Walensky, M.D., M.P.H., endorsed the Advisory Committee on Immunization Practices’, ACIP, recommendation that all children 6 months - 5 years of age should receive a COVID-19 vaccine. This expands eligibility to 20 million additional children and Americans ages 6 months and older are now eligible for vaccinations with the Pfizer-BioNTech or Moderna vaccines to better protect them from COVID-19. All children, including children who have already had COVID-19, should get vaccinated. Walensky signed off on two doses of Moderna's vaccine in children six months - 5 years and three doses of Pfizer's vaccine six months - 4 years.
Covid-19 is the leading cause of infectious disease-related death in ages 0 - 19 years old and the seventh most common of all causes of death according to Dr. Daley, senior investigator with the Institute for Health Research at Kaiser Permanente Colorado. The data also shows deaths can be prevented through vaccination, Dr. Matthew Daley said in an ACIP meeting.
FDA NEWS RELEASE
Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for Children Down to 6 Months of Age.
Evaluation of the Moderna COVID-19 Vaccine for Individuals 6 Months through 17 Years of Age.
In this analysis, the vaccine was 50.6% effective in preventing COVID-19. Among participants 2 through 5 years of age, the vaccine was 36.8% effective in preventing COVID-19.
2. Children 6 years through 11 years of age: In the FDA analysis, the immune response was comparable to the immune response of the adults.
3. Adolescents 12 through 17 years of age: In this analysis, the immune response of adolescents was comparable to the immune response of the older participants.
Children 6 months through 5 years of age: In the clinical trial the most commonly reported side effects across all age groups included:
The most commonly reported side effects in the clinical trial participants for both the 6 - 11 age group and the 12 - 17 age group include:
Evaluation of the Pfizer-BioNTech COVID-19 Vaccine for Children 6 Months through 4 Years of Age. The effectiveness and safety data evaluated and analyzed by the FDA for the Pfizer-BioNTech COVID-19 Vaccine were generated in an ongoing, randomized, blinded, placebo-controlled clinical trial in the United States and internationally, which enrolled infants and children.
Risks of Myocarditis and Pericarditis. The FDA and CDC safety surveillance systems have identified increased risks of myocarditis, inflammation of the heart muscle and pericarditis, inflammation of tissue surrounding the heart, following vaccination with the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine, particularly following the second dose.
Ongoing Safety Monitoring. It is mandatory for ModernaTX Inc., Pfizer Inc., and vaccination providers, to report the following to the Vaccine Adverse Event Reporting System (VAERS) for these two COVID-19 vaccines:
Dr. Veronica McNally indicated she was "struck" by the impact Covid-19 has had on children and the numbers: 2 million cases, 20,000 hospitalizations and over 200 deaths
FDA decision on Novavax’s Covid shots could be delayed to review changes in manufacturing. PUBLISHED THU, JUN 9 2022, 7:00 AM EDT. UPDATED THU, JUN 9 2022, 2:57 PM EDT.
FDA authorization would allow Novavax to start shipping to the U.S. from its manufacturing partner, Serum Institute of India. The Centers for Disease Control and Prevention still needs to sign off on the vaccine before pharmacies and other health-care providers could start administering the shots.
Novavax, a small Maryland biotech company, was an original participant of Operation Warp Speed, the race to develop a Covid vaccine in 2020, receiving $1.8 billion. Novavax asked the FDA to authorize its two-dose vaccine late January. While awaiting authorization in the U.S., the biotech company’s shots have been authorized in 40 countries, including Australia, Canada and the European Union.
The U.S. Food and Drug Administration said Novavax Inc's vaccine reduces the risk of mild-to-severe COVID-19 and could provide some level of protection against the Omicron variant.
The FDA analyzed data from Novavax's trial before the Omicron and Delta variant became the dominant strains.
In the study, which enrolled 30,000 adults in the United States and Mexico, the vaccine efficacy was 90.4%. The FDA also flagged the possible risk of myocarditis, a type of heart inflammation also associated with rival mRNA vaccines, after the Novavax shot.
How to Protect Yourself? Getting vaccinated is your best bet!
IT’S NOT OVER!
Stay safe. Mask. Social distance. Frequent hand washing. Avoid crowds
ALWAYS CONSULT YOUR PERSONAL HEALTH CARE PROFESSIONAL
1756 N. Riverside Ave
Rialto, CA 92376
Phone: 909 879-1059
Fax : 909 879-1043
Monday 10 am - 4:00 pm Tuesday 10 am - 4:00 pm
Wednesday 10 am - 4:00 pm
Thursday 10 am - 4:00 pm
Friday 10 am - 4:00 pm
HOLIDAY HOURS MAY VARY
10:30 am - 3 pm
Phone orders are encouraged. Large orders prior to 10:30 am
Deliveries not available during covid restrictions.
Stop in to check out all the items currently discounted for your personal resolutions.